Drug
Zolbetuximab
Zolbetuximab: highest development phase Phase 3, developed by Astellas. 1 trial record tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| zolbetuximab NCT06901531 | Phase 3 | Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer |
Latest
No recent events.
Follow Zolbetuximab on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.